末稍血管栓塞保護裝置(心血管) - 全球市場的分析與預測模式
Peripheral Embolic Protection Devices (Cardiovascular) - Global Market Analysis and Forecast Model
對象企業:Medtronic plc，Abbott Laboratories，Boston Scientific Corp，Cardinal Health Inc，Allium Medical Solutions Ltd
Peripheral Embolic Protection Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Peripheral Embolic Protection Devices market for the year 2020 and beyond. A narrowing of arteries due to the build-up of plaque occurs in conditions such as peripheral vascular disease, carotid artery stenosis and renal artery stenosis. Angioplasty is a minimally invasive interventional procedure that is used to unblock an artery with excessive plaque build-up in order to restore normal blood flow. Embolic debris may become dislodged during angioplasty procedures, which if left alone can cause a pulmonary embolism. To protect against distal embolic events, EPD are designed to capture and remove debris that may get dislodged during interventional procedures. Present technologies for Embolic Protection Devices (EPD) employ three important strategies: distal occlusion, proximal occlusion and distal filtration.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Peripheral Embolic Protection Devices market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Medtronic plc, Abbott Laboratories, Boston Scientific Corp, Cardinal Health Inc, Allium Medical Solutions Ltd
Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -